Skip to main content

Media Category: Progressive MS

Thomas Berger : Managing Multiple Sclerosis Relapses – From Accurate Diagnosis to Effective Treatment

In this short video interview, Thomas Berger explains how to accurately identify and manage relapses in multiple sclerosis, highlighting why correct assessment is fundamental for both acute treatment decisions and long-term disease management. Watch the interview How should MS relapses be assessed and treated? In the interview, Thomas Berger shares a practical, experience-based approach to relapse management, grounded in everyday clinical practice rather than theory alone. Key points discussed include: Why confirming a true relapse is the most critical prerequisite before...

Continue reading

Bart Van Wijmeersch: How to detect progression?

Professor Bart Van Wijmeersch shares his clinical perspective on one of the most critical challenges in MS care: detecting progression. In this short interview recorded at EAN 2025 in Helsinki, he discusses the subtle signs of disease evolution, the importance of proactive monitoring, and how timely recognition of progression can influence treatment strategy and long-term outcomes. “How to detect progression?” Interested to watch the interview? Log-in or subscribe Curious to learn more about the expert behind this interview? Visit...

Continue reading

Carlo Pozzilli on the topic of Progression in Multiple Sclerosis

“Why is ‘progression in Multiple Sclerosis’ so relevant for neurologists?” * Please note that all the captions were generated automatically. If they do not appear, click on CC in the navigation. Interested in the next interview question? “What should neurologists do with the concept of ‘progression’ in their clinical practice?” Log-in or subscribe. Curious to learn more about the expert behind this interview? Visit Carlo Pozzilli’s full biography for more insights into her expertise. ...

Continue reading

Beyond EDSS: How to monitor disease progression in MS

Key takeaways Limitations of EDSS – The EDSS alone may not capture the full scope of MS progression, especially in cases where deterioration occurs independently of relapses (PIRA). Smoldering MS – MS can progress silently, with neurodegeneration happening beneath the surface, even when clinical symptoms seem stable. This requires a broader monitoring strategy. Multimodal Monitoring – Effective disease monitoring should go beyond neurological exams, integrating: Clinical assessments and patient-reported outcomes (PROs) Imaging techniques, such as MRI biomarkers and advanced...

Continue reading

Bart Van Wijmeersch on subtle progression in MS and MS prognosis

BIOGRAPHY Bart Van Wijmeersch Bart Van Wijmeersch is a neurologist specialized in Multiple Sclerosis. He is medical director of the Rehabilitation and MS Center in Pelt where he leads the multidisciplinary MS-team. Furthermore, he is an associate professor of Neurology at the University of Hasselt, affiliated with the Biomedical Institute, where he’s involved in pre-clinical as well as the clinical research on MS at the biomedical institute (BIOMED). He has a supporting role in all the immunological research on blood- and CSF samples of persons with MS and in EAE-animal...

Continue reading

Update on Neuroimaging Techniques to Detect Activity and Progression in MS: The Role of Novel Markers for Chronic Active Inflammation (PRLs, SELs)

•The central vein sign could be used for differential diagnosis. •PRLs appear in the early stages and are more common in inflammatory stages. •PRLs are related to more aggressive disease •Brain atrophy assessed could help us to assess progression •Smouldering MS and progressive MS can be imaged using classic and novel techniques •SELs are related to progressive phases of the disease BIOGRAPHY CELIA OREJA-GUEVARA Prof. Celia Oreja-Guevara is Vice Chair of Neurology and Head of Multiple Sclerosis Center at the University Hospital San Carlos, Madrid and...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.